Abstract

Dear Readers, we are pleased to present you the second Pharma Horizion Panel Discussion for 2018. 

This time the topic we asked companies to express their opinion on is the Parenteral Drug Manufacturing Process. 

Eight enterprises accepted to join this project: Bormioli Pharma, Corden, Grifols, Lyophilization Technology, Pia Group, Piramal, Shl Group and West Pharmaceutical Services.

All of them were offered the opportunity to think about and provide their thoughts on some different aspects related to the discussion topic. Among them, future perspectives on technical and manufacturing process advancements, the relevance of quality by design, opportunities and treats related to the prefilled syringes world, how to address the mandatory aspects of sterility, quality, productivity and safety of the products, packaging and standardization issues.

Here are their opinions. Enjoy the reading.

How to Face the Glass Vials Wave of Innovation Leveraging on Processes
Improving glass vials performances starting from quality by design approach

ANNA MALORI
Business Development Manager,
Bormioli Pharma

"The packaging innovation drive: improved shatterproof and chemical-resistant properties as well as security features"

In the world market for parenteral products, glass vials continue to be the most widely used primary containers, mainly thanks to strong barrier properties and a broad range of applications served. This trend is expected to be confirmed also over the next years, with a global demand for this type of container that will reach $5.7 billion in 2024 (1).

From the packaging manufacturer standpoint, the increasing demand for parenteral glass vials results in a constant need for innovation and product de ... ...